losartan has been researched along with Bile Duct Obstruction, Extrahepatic in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afroze, SH | 1 |
| Munshi, MK | 1 |
| MartÃnez, AK | 1 |
| Uddin, M | 1 |
| Gergely, M | 1 |
| Szynkarski, C | 1 |
| Guerrier, M | 1 |
| Nizamutdinov, D | 1 |
| Dostal, D | 1 |
| Glaser, S | 1 |
1 other study available for losartan and Bile Duct Obstruction, Extrahepatic
| Article | Year |
|---|---|
Activation of the renin-angiotensin system stimulates biliary hyperplasia during cholestasis induced by extrahepatic bile duct ligation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Bile Ducts, Extrahepatic; Cell Lin | 2015 |